Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future

[1]  M. Snyder,et al.  The double life of NK receptors: stimulation or co-stimulation? , 2004, Trends in immunology.

[2]  L. Moretta,et al.  IL‐21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig‐like receptors , 2003, European journal of immunology.

[3]  S. Chouaib,et al.  CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. , 2003, Cancer research.

[4]  L. Moretta,et al.  HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Corthésy,et al.  Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. , 2003, Blood.

[6]  D. Tough,et al.  IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells , 2003, The Journal of Immunology.

[7]  P. Bjorkman,et al.  Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.

[8]  J. Trowsdale,et al.  Different and Divergent Regulation of the KIR2DL4 and KIR3DL1 Promoters1 , 2003, The Journal of Immunology.

[9]  T. Mikayama,et al.  Differential Regulation of Killer Cell Lectin-Like Receptor G1 Expression on T Cells 1 , 2003, The Journal of Immunology.

[10]  R. V. van Lier,et al.  Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV1 , 2003, The Journal of Immunology.

[11]  S. Olofsson,et al.  LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients , 2003, The Lancet.

[12]  H. Young,et al.  Expression of IFN-γ Upon Triggering of Activating Ly49D NK Receptors In Vitro and In Vivo: Costimulation with IL-12 or IL-18 Overrides Inhibitory Receptors 1 , 2003, The Journal of Immunology.

[13]  Michael J. Wilson,et al.  DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells , 2003, The Journal of experimental medicine.

[14]  L. Lanier,et al.  A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition , 2002, The Journal of experimental medicine.

[15]  J. Belisle,et al.  HLA-E–dependent Presentation of Mtb-derived Antigen to Human CD8+ T Cells , 2002, The Journal of experimental medicine.

[16]  C. Peacock,et al.  Dynamics of Ly49 expressing cytotoxic lymphocyte subsets in response to virus infection. , 2002, Microbes and infection.

[17]  R. Kiessling,et al.  IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. , 2002, The Journal of clinical investigation.

[18]  D. Voehringer,et al.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). , 2002, Blood.

[19]  H. Trompeter,et al.  Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells1 , 2002, The Journal of Immunology.

[20]  S. Chouaib,et al.  Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. , 2002, Blood.

[21]  J. Sprent,et al.  Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T Cells , 2002, The Journal of experimental medicine.

[22]  R. Winchester,et al.  TCR specificity dictates CD94/NKG2A expression by human CTL. , 2002, Immunity.

[23]  Y. Chwae,et al.  Molecular Mechanism of the Activation-Induced Cell Death Inhibition Mediated by a p70 Inhibitory Killer Cell Ig-Like Receptor in Jurkat T Cells1 , 2002, The Journal of Immunology.

[24]  J. Abramson,et al.  An unusual inhibitory receptor--the mast cell function-associated antigen (MAFA). , 2002, Molecular immunology.

[25]  R. Biassoni,et al.  Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Ahmed,et al.  Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells1 , 2002, The Journal of Immunology.

[27]  J. Altman,et al.  CD94/NKG2 Expression Does Not Inhibit Cytotoxic Function of Lymphocytic Choriomeningitis Virus-Specific CD8+ T Cells1 , 2002, The Journal of Immunology.

[28]  F. Jotereau,et al.  Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1 , 2002, The Journal of Immunology.

[29]  A. Toubert,et al.  Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis. , 2002, International immunology.

[30]  D. Speiser,et al.  Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma. , 2002, Immunology letters.

[31]  W. O'Fallon,et al.  Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells1 , 2002, The Journal of Immunology.

[32]  G. Leclercq,et al.  Expression of Inhibitory Receptors Ly49E and CD94/NKG2 on Fetal Thymic and Adult Epidermal TCR Vγ3 Lymphocytes1 , 2002, The Journal of Immunology.

[33]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[34]  P. Jensen,et al.  CD94-NKG2A receptors regulate antiviral CD8+ T cell responses , 2002, Nature Immunology.

[35]  M. Daëron.  Immunoreceptor Tyrosine Based Inhibition Motifs (ITIMs) , 2002 .

[36]  W. O'Fallon,et al.  Formation of the Killer Ig-Like Receptor Repertoire on CD4 CD28 T Cells , 2002 .

[37]  R. Kiessling,et al.  IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD 94 / NKG 2 A-dependent mechanism , 2002 .

[38]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.

[39]  R. Biassoni,et al.  What is a natural killer cell? , 2002, Nature Immunology.

[40]  S. Anfossi,et al.  The analysis of the natural killer‐like activity of human cytolytic T lymphocytes revealed HLA‐E as a novel target for TCR α/β‐mediated recognition , 2001 .

[41]  T. Hanke,et al.  Expression of inhibitory "killer cell lectin‐like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells , 2001, European journal of immunology.

[42]  Marc Bonneville,et al.  Autoreactivity by design: innate B and T lymphocytes , 2001, Nature Reviews Immunology.

[43]  D. Voehringer,et al.  Viral Infections Induce Abundant Numbers of Senescent CD8 T Cells1 , 2001, The Journal of Immunology.

[44]  J. Trowsdale,et al.  Genetic and functional relationships between MHC and NK receptor genes. , 2001, Immunity.

[45]  P. Duplay,et al.  Cutting Edge: Ly49A Inhibits TCR/CD3-Induced Apoptosis and IL-2 Secretion1 , 2001, The Journal of Immunology.

[46]  É. Vivier,et al.  Biology of T memory type 1 cells , 2001, Immunological reviews.

[47]  B. Wilhelm,et al.  Comparative analysis of the promoter regions and transcriptional start sites of mouse Ly49 genes , 2001, Immunogenetics.

[48]  P. Parham,et al.  The Repertoire of Killer Cell Ig-Like Receptor and CD94:NKG2A Receptors in T Cells: Clones Sharing Identical αβ TCR Rearrangement Express Highly Diverse Killer Cell Ig-Like Receptor Patterns1 , 2001, The Journal of Immunology.

[49]  P. Parham,et al.  Differential Expression of Leukocyte Receptor Complex-Encoded Ig-Like Receptors Correlates with the Transition from Effector to Memory CTL1 , 2001, The Journal of Immunology.

[50]  F. Takei,et al.  The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes. , 2001, International immunology.

[51]  R. Biassoni,et al.  CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. , 2001, Blood.

[52]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[53]  T. Hanke,et al.  Cumulative Inhibition of NK Cells and T Cells Resulting from Engagement of Multiple Inhibitory Ly49 Receptors1 , 2001, The Journal of Immunology.

[54]  M. Bonneville,et al.  Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements1 , 2001, The Journal of Immunology.

[55]  M. Colonna,et al.  Ig-Like Transcript 2 (ILT2)/Leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization1 , 2001, The Journal of Immunology.

[56]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[57]  K. Triantafilou,et al.  Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells , 2001, Nature Immunology.

[58]  A. Diehl,et al.  Emergence of CD8+ T Cells Expressing NK Cell Receptors in Influenza A Virus-Infected Mice1 , 2000, The Journal of Immunology.

[59]  G. Anastasi,et al.  The CD85/LIR-1/ILT2 Inhibitory Receptor Is Expressed by All Human T Lymphocytes and Down-Regulates Their Functions1 , 2000, The Journal of Immunology.

[60]  R. Vance,et al.  Analysis of Qa-1bPeptide Binding Specificity and the Capacity of Cd94/Nkg2a to Discriminate between Qa-1–Peptide Complexes , 2000, The Journal of experimental medicine.

[61]  T. Kuijpers,et al.  Cytolytic Mechanisms and Expression of Activation-Regulating Receptors on Effector-Type CD8+CD45RA+CD27− Human T Cells , 2000, The Journal of Immunology.

[62]  J. Ellwart,et al.  Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis1 , 2000, The Journal of Immunology.

[63]  S. Chouaib,et al.  Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. , 2000, Blood.

[64]  T. Hanke,et al.  NK cell expression of the killer cell lectin‐like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules , 2000, European journal of immunology.

[65]  A. McMichael,et al.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. , 2000, Science.

[66]  D. Speiser,et al.  Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression1 , 2000, The Journal of Immunology.

[67]  U. Lendahl,et al.  Ly49A expression on T cells alters T cell selection. , 2000, International immunology.

[68]  L. Karlsson,et al.  KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement , 2000, Nature.

[69]  Kathleen M. Smith,et al.  Transgenic Expression of Ly-49A in Thymocytes Alters Repertoire Selection1 , 2000, The Journal of Immunology.

[70]  D. Raulet,et al.  Memory CD8 T lymphocytes express inhibitory MHC‐specific Ly49 receptors , 2000, European journal of immunology.

[71]  D. Voehringer,et al.  Genomic structure, alternative splicing, and physical mapping of the killer cell lectin-like receptor G1 gene (KLRG1), the mouse homologue of MAFA , 2000, Immunogenetics.

[72]  J. Altman,et al.  Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. , 1999, Journal of immunology.

[73]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[74]  P. Kourilsky,et al.  Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice. , 1999, Blood.

[75]  D. Speiser,et al.  In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes , 1999, The Journal of experimental medicine.

[76]  J. Strominger,et al.  Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2‐A and the activating receptor CD94/NKG2‐C to HLA‐E , 1999, The EMBO journal.

[77]  D. Busch,et al.  Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. , 1999, Immunity.

[78]  D. Speiser,et al.  CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients , 1999, European journal of immunology.

[79]  É. Vivier,et al.  Differential regulation of killer cell Ig‐like receptors and CD94 lectin‐like dimers on NK and T lymphocytes from HIV‐1‐infected individuals , 1999, European journal of immunology.

[80]  M. Colonna,et al.  Organization of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4 , 1999, Mammalian Genome.

[81]  R. Bellomo,et al.  Transforming growth factor‐β‐induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes , 1999, European journal of immunology.

[82]  Eric O Long,et al.  Regulation of immune responses through inhibitory receptors. , 1999, Annual review of immunology.

[83]  J. Altman,et al.  Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.

[84]  G. Cook,et al.  MAFA‐L, an ITIM‐containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells , 1998, European journal of immunology.

[85]  C. Figdor,et al.  Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. , 1998, Journal of immunology.

[86]  R. Brent,et al.  LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[87]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[88]  R. Bellomo,et al.  HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Ortaldo,et al.  The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells. , 1998, Journal of immunology.

[90]  Eric Vivier,et al.  Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases , 1998, European journal of immunology.

[91]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[92]  M. Bonneville,et al.  Control of self‐reactive cytotoxic T lymphocytes expressing γδ T cell receptors by natural killer inhibitory receptors , 1997 .

[93]  A. Fauci,et al.  Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[94]  F. Vély,et al.  Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. , 1997, Journal of immunology.

[95]  A. Trautmann,et al.  Reconstituted Killer Cell Inhibitory Receptors for Major Histocompatibility Complex Class I Molecules Control Mast Cell Activation Induced via Immunoreceptor Tyrosine-based Activation Motifs* , 1997, The Journal of Biological Chemistry.

[96]  R. Biassoni,et al.  HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. , 1997, International immunology.

[97]  P. Coulie,et al.  Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. , 1997, Immunity.

[98]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[99]  A. Fauci,et al.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[100]  L. Lanier,et al.  Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles , 1996, The Journal of experimental medicine.

[101]  P. Parham,et al.  Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype , 1996, The Journal of experimental medicine.

[102]  C. Falk,et al.  Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells , 1995, The Journal of experimental medicine.

[103]  M. Guthmann,et al.  A secretion inhibitory signal transduction molecule on mast cells is another C-type lectin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[104]  P. Parham,et al.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. , 1995, Science.

[105]  S. Ferrini,et al.  Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. , 1995, International immunology.

[106]  S. Sforzini,et al.  T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function , 1994, European journal of immunology.

[107]  E. Ciccone,et al.  Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition , 1990, The Journal of experimental medicine.

[108]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.